Philogen S.p.A. (PHIL.MI) has a MoatMap StockRank of 100/100 based on Quality (92/100), Value (70/100), and Momentum (51/100) factor scores. The current signal is STRONG BUY. Philogen S.p.A., an Italian healthcare company, lacks a direct and compelling link to the identified macro inflection points that would create an asymmetric risk-reward opportunity. While healthcare can be a quality sector, this specific biotech firm does not align with any of the high-conviction macro tailwinds or contrarian views that the fund is targeting for a concentrated position.
| Price | $27.35 |
| Market Cap | $1.1B |
| P/E (TTM) | 3.89 |
| P/E (Forward) | -55.14 |
| Price/Book | 7.10 |
| Return on Equity | 89.6% |
| Return on Invested Capital | 67.5% |
| Debt/Equity | 2.92 |
| Gross Margin | 87.6% |
| Operating Margin | 87.7% |
| Revenue Growth | 310.8% |
| Dividend Yield | 3.1% |
| Free Cash Flow | $274M |
Philogen S.p.A. operates in the Biotechnology industry, part of the Healthcare sector (Italy).